OncoMatch/Clinical Trials/NCT05331911

Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors

Is NCT05331911 recruiting? Yes, currently enrolling (May 2026). This Phase 4 trial studies multiple treatments including Propofol and Sevoflurane for hepatocellular carcinoma.

Phase 4RecruitingKaohsiung Medical University Chung-Ho Memorial HospitalNCT05331911Data as of May 2026

Treatment: Propofol · Sevoflurane — This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary Hepatocellular carcinoma. The study will enroll approximately 500 volunteers to compare the progression-free or overall survival in patients undergoing elective partial hepatectomy for primary liver tumors between propofol and sevoflurane for the maintenance of anesthesia.

Check if I qualify

Extracted eligibility criteria

Cancer type

Hepatocellular Carcinoma

Performance status

ASA 1–3

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify